BOWLIN MICHAEL R 4
4 · Edwards Lifesciences Corp · Filed Feb 27, 2013
Insider Transaction Report
Form 4
BOWLIN MICHAEL R
Director
Transactions
- Exercise/Conversion
Common Stock
2013-02-26$22.71/sh+3,520$79,957→ 77,908 total - Sale
Common Stock
2013-02-26$87.09/sh−3,520$306,557→ 74,388 total - Exercise/Conversion
Director Stock Option (Right to Acquire)
2013-02-26−3,520→ 0 totalExercise: $22.71From: 2006-07-03Exp: 2013-07-12→ Common Stock (3,520 underlying)
Footnotes (2)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- [F2]This transaction was executed in multiple trades at prices ranging from $87.01 to $87.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.